Alterola Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
For the nine months, net loss was USD 1.72 million compared to USD 3.21 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0037 USD | -31.48% | -31.48% | +2.78% |
1st Jan change | Capi. | |
---|---|---|
+2.78% | 5.12M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |